Quali-quantitative synthesis of the global scenario of patent families about leprosy

Detalhes bibliográficos
Autor(a) principal: Meneghin,Rogério Almeida
Data de Publicação: 2021
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Ciência & Saúde Coletiva (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232021001105411
Resumo: Abstract The work presents the analysis and synthesis of patent families about leprosy worldwide in the last 20 years. Three technological aspects were defined for the study of both portfolios, thus defined: diagnostic, drug/treatment and vaccine. Three thousand and three hundred twenty-three (3323) patent families were identified (790 for diagnostic, 1515 for drug and 1018 for vaccine). Fifty-eight (58) patent holders were identified and analyzed, with the most expressive portfolio of patent families, distributed in 13 countries. For the recovery of patent families, the ORBIT Intelligence® system from QUESTEL® was used. Using quantitative and qualitative analysis and synthesis, the patterns of five strategic indicators on the global patent scenario about leprosy were observed, namely: holders of patent families; the years of filing for unionist priority for patent families; countries of unionist priority for patent families; the legal status of filed patent families; and the legal status of patent families by country of protection. It is suggested that new public policies be created to encourage synergy between patent families and the social determinants of neglected populations, in order to induce a safe path to technological independence and better performance in the fight against leprosy in the Brazil.
id ABRASCO-2_a6aff25ca3264b90f3facf7b2136022e
oai_identifier_str oai:scielo:S1413-81232021001105411
network_acronym_str ABRASCO-2
network_name_str Ciência & Saúde Coletiva (Online)
repository_id_str
spelling Quali-quantitative synthesis of the global scenario of patent families about leprosyLeprosy and patentAbstract The work presents the analysis and synthesis of patent families about leprosy worldwide in the last 20 years. Three technological aspects were defined for the study of both portfolios, thus defined: diagnostic, drug/treatment and vaccine. Three thousand and three hundred twenty-three (3323) patent families were identified (790 for diagnostic, 1515 for drug and 1018 for vaccine). Fifty-eight (58) patent holders were identified and analyzed, with the most expressive portfolio of patent families, distributed in 13 countries. For the recovery of patent families, the ORBIT Intelligence® system from QUESTEL® was used. Using quantitative and qualitative analysis and synthesis, the patterns of five strategic indicators on the global patent scenario about leprosy were observed, namely: holders of patent families; the years of filing for unionist priority for patent families; countries of unionist priority for patent families; the legal status of filed patent families; and the legal status of patent families by country of protection. It is suggested that new public policies be created to encourage synergy between patent families and the social determinants of neglected populations, in order to induce a safe path to technological independence and better performance in the fight against leprosy in the Brazil.ABRASCO - Associação Brasileira de Saúde Coletiva2021-11-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232021001105411Ciência & Saúde Coletiva v.26 n.11 2021reponame:Ciência & Saúde Coletiva (Online)instname:Associação Brasileira de Saúde Coletiva (ABRASCO)instacron:ABRASCO10.1590/1413-812320212611.01452021info:eu-repo/semantics/openAccessMeneghin,Rogério Almeidaeng2021-11-24T00:00:00Zoai:scielo:S1413-81232021001105411Revistahttp://www.cienciaesaudecoletiva.com.brhttps://old.scielo.br/oai/scielo-oai.php||cienciasaudecoletiva@fiocruz.br1678-45611413-8123opendoar:2021-11-24T00:00Ciência & Saúde Coletiva (Online) - Associação Brasileira de Saúde Coletiva (ABRASCO)false
dc.title.none.fl_str_mv Quali-quantitative synthesis of the global scenario of patent families about leprosy
title Quali-quantitative synthesis of the global scenario of patent families about leprosy
spellingShingle Quali-quantitative synthesis of the global scenario of patent families about leprosy
Meneghin,Rogério Almeida
Leprosy and patent
title_short Quali-quantitative synthesis of the global scenario of patent families about leprosy
title_full Quali-quantitative synthesis of the global scenario of patent families about leprosy
title_fullStr Quali-quantitative synthesis of the global scenario of patent families about leprosy
title_full_unstemmed Quali-quantitative synthesis of the global scenario of patent families about leprosy
title_sort Quali-quantitative synthesis of the global scenario of patent families about leprosy
author Meneghin,Rogério Almeida
author_facet Meneghin,Rogério Almeida
author_role author
dc.contributor.author.fl_str_mv Meneghin,Rogério Almeida
dc.subject.por.fl_str_mv Leprosy and patent
topic Leprosy and patent
description Abstract The work presents the analysis and synthesis of patent families about leprosy worldwide in the last 20 years. Three technological aspects were defined for the study of both portfolios, thus defined: diagnostic, drug/treatment and vaccine. Three thousand and three hundred twenty-three (3323) patent families were identified (790 for diagnostic, 1515 for drug and 1018 for vaccine). Fifty-eight (58) patent holders were identified and analyzed, with the most expressive portfolio of patent families, distributed in 13 countries. For the recovery of patent families, the ORBIT Intelligence® system from QUESTEL® was used. Using quantitative and qualitative analysis and synthesis, the patterns of five strategic indicators on the global patent scenario about leprosy were observed, namely: holders of patent families; the years of filing for unionist priority for patent families; countries of unionist priority for patent families; the legal status of filed patent families; and the legal status of patent families by country of protection. It is suggested that new public policies be created to encourage synergy between patent families and the social determinants of neglected populations, in order to induce a safe path to technological independence and better performance in the fight against leprosy in the Brazil.
publishDate 2021
dc.date.none.fl_str_mv 2021-11-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232021001105411
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232021001105411
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1413-812320212611.01452021
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv ABRASCO - Associação Brasileira de Saúde Coletiva
publisher.none.fl_str_mv ABRASCO - Associação Brasileira de Saúde Coletiva
dc.source.none.fl_str_mv Ciência & Saúde Coletiva v.26 n.11 2021
reponame:Ciência & Saúde Coletiva (Online)
instname:Associação Brasileira de Saúde Coletiva (ABRASCO)
instacron:ABRASCO
instname_str Associação Brasileira de Saúde Coletiva (ABRASCO)
instacron_str ABRASCO
institution ABRASCO
reponame_str Ciência & Saúde Coletiva (Online)
collection Ciência & Saúde Coletiva (Online)
repository.name.fl_str_mv Ciência & Saúde Coletiva (Online) - Associação Brasileira de Saúde Coletiva (ABRASCO)
repository.mail.fl_str_mv ||cienciasaudecoletiva@fiocruz.br
_version_ 1754213048468373504